EGFR-HER2 inhibitor Erlotinib mesylate, Purity ≥98%

Cat. No.: X24-05-ZQ651

EGFR-HER2 inhibitor Erlotinib mesylate, Purity ≥98%

Synonym: 248594-19-6; Tarceva; CP-358774; OSI-774; NSC 718781; R 1415; EGFR-HER2 inhibitor

  • CAS Number: 248594-19-6
  • Compound CID: 9913428
Product Size
100 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Erlotinib mesylate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR.
Molecular Weight
489.54
Molecular Formula
C23H27N3O7S
Targets
EGFR: 2 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Erlotinib mesylate is applied in research to examine its EGFR tyrosine kinase inhibition and effects on tumor growth.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0